易瑞生物：2025年上半年净利润233.95万元，同比扭亏为盈

Core Viewpoint - 易瑞生物 reported a revenue of 109 million yuan for the first half of 2025, representing a year-on-year growth of 5.44% [1] - The net profit attributable to shareholders was 2.3395 million yuan, a significant improvement from a loss of 1.5595 million yuan in the same period last year [1] - The company announced plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves [1] Financial Performance - Revenue for the first half of 2025 reached 109 million yuan, marking a 5.44% increase compared to the previous year [1] - The net profit for the period was 2.3395 million yuan, a turnaround from a loss of 1.5595 million yuan in the prior year [1] Dividend Policy - The company will not distribute cash dividends [1] - There will be no issuance of bonus shares [1] - No capital increase from reserves is planned [1]